H. B. Fuller (NYSE:FUL) Director Buys 465 Shares of Company Stock

October 2, 2026 by InsiderTrades.com

Key Points

Director Michael Happe bought 2,000 H. B. Fuller shares at an average price of $49.62, spending $99,240 and increasing his direct ownership by nearly 149% to 3,343 shares.
H. B. Fuller reported quarterly EPS of $1.52, ahead of the $1.47 consensus, while revenue rose 5.2% year over year to $938.17 million but missed estimates. The company also declared a $0.245 quarterly dividend, representing a 2.0% yield.
Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $64.62, although several firms recently lowered their targets. Institutional investors own approximately 95.93% of the stock.

H. B. Fuller Company (NYSE:FUL - Get Free Report) Director Celine Martin acquired 465 shares of the stock in a transaction dated Wednesday, September 30th. The stock was acquired at an average price of $49.50 per share, for a total transaction of $23,017.50. Following the purchase, the director directly owned 465 shares in the company, valued at approximately $23,017.50. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink.

H. B. Fuller Stock Performance

Industrial Chemicals: 3 Stocks Poised for Growth in the New Year

Shares of NYSE FUL opened at $50.18 on Friday. The firm has a 50 day moving average of $55.24 and a 200 day moving average of $58.18. The company has a current ratio of 1.82, a quick ratio of 1.10 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $2.70 billion, a price-to-earnings ratio of 13.98, a price-to-earnings-growth ratio of 0.61 and a beta of 0.99. H. B. Fuller Company has a 12-month low of $46.70 and a 12-month high of $68.63.

H. B. Fuller (NYSE:FUL - Get Free Report) last released its quarterly earnings results on Thursday, September 24th. The specialty chemicals company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.05. The business had revenue of $938.17 million for the quarter, compared to the consensus estimate of $945.59 million. H. B. Fuller had a net margin of 5.56% and a return on equity of 12.65%. The company's quarterly revenue was up 5.2% on a year-over-year basis. During the same period last year, the firm earned $1.26 earnings per share. On average, research analysts anticipate that H. B. Fuller Company will post 4.88 earnings per share for the current year.

H. B. Fuller Dividend Announcement

Acuity Brands Lights Up Opportunity In The Industrial Sector

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 29th. Stockholders of record on Thursday, October 15th will be paid a $0.2450 dividend. This represents a $0.98 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Thursday, October 15th. H. B. Fuller's dividend payout ratio is 27.30%.

More H. B. Fuller News

Here are the key news stories impacting H. B. Fuller this week:

Positive Sentiment: Activist investor Ancora raised its offer for H. B. Fuller’s building adhesives unit to as much as $1.4 billion in cash. A higher bid, reportedly backed by Fortress, improves the prospects of a sale that could unlock value and increases pressure on H. B. Fuller’s board to consider strategic alternatives. Ancora raises bid for H.B. Fuller building unit
Positive Sentiment: Multiple directors purchased approximately $620,000 of FUL shares. Recent buyers included Celine Martin, Michael Happe, Srilata Zaheer, Charles T. Lauber, Teresa Rasmussen, Daniel L. Florness and Thomas W. Handley, with purchases generally priced near $49 to $50 per share. The transactions substantially increased several directors’ holdings and may signal confidence in the company’s valuation. H. B. Fuller insider purchase filing
Neutral Sentiment: Recent quarterly results offered some fundamental support. H. B. Fuller reported adjusted EPS of $1.52, ahead of the $1.47 consensus, while revenue rose 5.2% year over year to roughly $938 million. However, revenue fell modestly short of expectations, limiting the positive impact of the earnings report.
Negative Sentiment: Analyst caution could restrain the stock. JPMorgan and Deutsche Bank issued less optimistic outlooks, while Deutsche Bank reportedly reduced its price target, highlighting concerns about valuation and the company’s operating outlook despite continued expectations for potential upside. Analyst outlook for H. B. Fuller

Analyst Upgrades and Downgrades

Dividend King H.B. Fuller Rises On Hopes For Rebound

Several analysts have issued reports on the company. JPMorgan Chase & Co. cut their price target on H. B. Fuller from $67.00 to $66.00 and set an "overweight" rating for the company in a report on Monday. UBS Group set a $69.00 target price on shares of H. B. Fuller in a report on Friday, June 26th. Robert W. Baird decreased their target price on shares of H. B. Fuller from $75.00 to $65.00 and set an "outperform" rating on the stock in a research note on Friday, September 25th. The Goldman Sachs Group set a $67.00 price objective on shares of H. B. Fuller in a research report on Friday, June 26th. Finally, Citigroup decreased their target price on H. B. Fuller from $75.00 to $63.00 and set a "buy" rating on the stock in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, H. B. Fuller currently has a consensus rating of "Moderate Buy" and a consensus price target of $64.62.

Check Out Our Latest Stock Report on H. B. Fuller

Hedge Funds Weigh In On H. B. Fuller

Several institutional investors have recently bought and sold shares of the stock. Hantz Financial Services Inc. lifted its stake in H. B. Fuller by 432.9% in the 4th quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company's stock worth $46,000 after purchasing an additional 632 shares in the last quarter. Parallel Advisors LLC grew its position in shares of H. B. Fuller by 85.6% during the first quarter. Parallel Advisors LLC now owns 1,034 shares of the specialty chemicals company's stock valued at $64,000 after purchasing an additional 477 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in shares of H. B. Fuller by 510.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,466 shares of the specialty chemicals company's stock valued at $87,000 after purchasing an additional 1,226 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of H. B. Fuller in the second quarter worth about $86,000. Finally, Bayban bought a new stake in shares of H. B. Fuller in the fourth quarter worth about $156,000. 95.93% of the stock is owned by hedge funds and other institutional investors.

H. B. Fuller Company Profile

(Get Free Report)

H.B. Fuller Company is a global manufacturer of adhesives, sealants and specialty chemical products. Its solutions are used to bond, seal, protect and assemble materials in commercial and industrial applications, including packaging, hygiene products, construction, transportation, electronics and durable goods.

The company offers products such as hot-melt, water-based and reactive adhesives, construction adhesives, sealants, coatings and specialty formulations. H.B. Fuller serves manufacturers, contractors and other commercial customers that require bonding and sealing solutions for products, components and building materials.

Founded in 1887 by Harvey Benjamin Fuller, the company has grown from a regional adhesive producer into an international supplier serving customers across North America, Europe, Asia-Pacific and Latin America.